INTEGER HOLDINGS CORPORATION Equity Method Investment, Other than Temporary Impairment
INTEGER HOLDINGS CORPORATION (ITGR) reported Equity Method Investment, Other than Temporary Impairment of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-02-23
- INTEGER HOLDINGS CORPORATION equity method investment, other than temporary impairment for the quarter ending 2025-12-31 was $0.00.
- INTEGER HOLDINGS CORPORATION equity method investment, other than temporary impairment for the quarter ending 2025-09-26 was $0.00, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION equity method investment, other than temporary impairment for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION equity method investment, other than temporary impairment for the quarter ending 2024-09-27 was $247.00K, a 92.40% decline year-over-year.
- INTEGER HOLDINGS CORPORATION equity method investment, other than temporary impairment for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- INTEGER HOLDINGS CORPORATION equity method investment, other than temporary impairment for fiscal 2024 was $247.00K, a 95.26% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION equity method investment, other than temporary impairment for fiscal 2023 was $5.21M.
- INTEGER HOLDINGS CORPORATION equity method investment, other than temporary impairment for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 | |
| 2025-09-26 | $0.00 10-Q · filed 2025-10-23 | $0.00 10-Q · filed 2025-10-23 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $247.00K derived: sum of 2 quarters · filed 2026-02-23 | $247.00K 10-K · filed 2026-02-23 | |
| 2024-09-27 | $247.00K 10-Q · filed 2025-10-23 | $247.00K 10-Q · filed 2025-10-23 | ||
| 2023-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $5.21M derived: sum of 2 quarters · filed 2026-02-23 | $5.21M 10-K · filed 2026-02-23 | |
| 2023-09-29 | $3.25M 10-Q · filed 2024-10-24 | $3.25M 10-Q · filed 2024-10-24 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $0.00 derived: sum of 2 quarters · filed 2025-02-20 | $0.00 10-K · filed 2025-02-20 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-26 | $0.00 10-Q · filed 2023-10-26 | ||
| 2021-12-31 | $86.00K 10-K · filed 2024-02-20 | |||
| 2020-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $369.00K derived: sum of 2 quarters · filed 2023-02-21 | $369.00K derived: sum of 3 quarters · filed 2023-02-21 | $369.00K 10-K · filed 2023-02-21 |
| 2020-10-02 | $0.00 10-Q · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | |
| 2020-07-03 | $0.00 10-Q · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $1.57M derived: sum of 3 quarters · filed 2022-02-22 | $1.57M 10-K · filed 2022-02-22 |
| 2019-09-27 | $0.00 10-Q · filed 2020-10-29 | $1.57M derived: sum of 2 quarters · filed 2020-10-29 | $1.57M 10-Q · filed 2020-10-29 | $1.57M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-28 | $1.57M 10-Q · filed 2020-07-30 | $1.57M 10-Q · filed 2020-07-30 | $1.57M derived: sum of 3 quarters · filed 2021-02-18 | $1.57M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-29 | $0.00 10-Q · filed 2019-05-03 | $0.00 derived: sum of 2 quarters · filed 2021-02-18 | $0.00 derived: sum of 3 quarters · filed 2021-02-18 | $0.00 derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $0.00 derived: sum of 2 quarters · filed 2021-02-18 | $0.00 derived: sum of 3 quarters · filed 2021-02-18 | $0.00 10-K · filed 2021-02-18 |
| 2018-09-28 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | |
| 2018-06-29 | $0.00 10-Q · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-30 | $0.00 10-Q · filed 2019-05-03 | |||
| 2017-12-29 | $5.25M 10-K · filed 2020-02-20 | |||
| 2016-12-30 | $1.57M 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |